JPRN-jRCT1041230068招募中2 期
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancer - NUPAT-10
Ebata Tomoki0 个研究点目标入组 50 人开始时间: 2023年8月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •1) diagnosed as pancreatic cancer by imiging studies
- •2) patients without distant metastasis (M0)
- •3) resectable pancreatic cancer
- •4) CA19-9 >100U/ml
- •5) age of 20-80
- •6) PS (ECOG) 0 or 1
- •7) initial treatment for the disease
- •8) without other malignancies
- •9) normal oral ingestion
- •10) without major organ failures
- •11) agreed by the patients
排除标准
- •1) serious allergy for any drug
- •2) active other malignancies
- •3) active infectious disease
- •4) neuropathy (>Grade 2)
- •5) administered with atanazavir
- •6) bowel obstruction or paresis
- •7) uncontrolable acites or pleural effusion
- •8) uncontrolable diabetes, hypertention, chirrosis, renal failure, ischemic cardiac disease, interstitial pneumonia
- •9) pregnant or lactating women
- •10) unable to join the clinical trial due to psychological condition
- •11) diarrea (>Grade 2)
- •12) administerd with S1
- •13) any other reasons by which doctors identified as inadequate
研究者
相似试验
已完成
不适用
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
已完成
1 期
The phaseI,II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with locally-advanced pancreatic cancerlocally-advanced pancreatic cancerJPRN-UMIN000016630Hiroshima University60
已完成
2 期
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49
已完成
2 期
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40
已完成
2 期
A phase II study of neoadjuvant chemotherapy with nab-paclitaxel followed by FEC in patitents with operable breast cancerbreast cancerJPRN-UMIN000030692kyushu Breast Cancer Study Group40